Stratton Parker syndrome: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 31: | Line 31: | ||
[[Category:Neurological Disorders]] | [[Category:Neurological Disorders]] | ||
{{No image}} | {{No image}} | ||
Revision as of 13:19, 18 March 2025
Stratton Parker Syndrome
Stratton Parker Syndrome (SPS) is a rare genetic disorder characterized by a combination of neurological, developmental, and physical abnormalities. It is named after Dr. Stratton Parker, who first described the syndrome in the early 21st century.
Symptoms
The symptoms of Stratton Parker Syndrome can vary widely among affected individuals, but commonly include:
- Neurological Issues: These may include seizures, developmental delays, and intellectual disabilities. Seizures are often one of the first signs of the syndrome.
- Physical Abnormalities: Individuals may present with distinctive facial features, skeletal anomalies, and growth retardation.
- Behavioral Challenges: Some patients exhibit autism spectrum disorder-like behaviors, including difficulties with social interaction and communication.
Causes
Stratton Parker Syndrome is caused by mutations in the SPK1 gene, which plays a crucial role in neural development. The mutation is typically inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.
Diagnosis
Diagnosis of Stratton Parker Syndrome is based on clinical evaluation, family history, and genetic testing. Genetic testing can confirm the presence of mutations in the SPK1 gene.
Treatment
There is currently no cure for Stratton Parker Syndrome. Treatment focuses on managing symptoms and may include:
- Anticonvulsant Medications: To control seizures.
- Physical Therapy: To address motor skill delays and improve mobility.
- Behavioral Therapy: To help manage behavioral issues and improve social skills.
Prognosis
The prognosis for individuals with Stratton Parker Syndrome varies. Some individuals may lead relatively normal lives with appropriate support, while others may have significant disabilities.
Research
Ongoing research is focused on understanding the genetic mechanisms underlying Stratton Parker Syndrome and developing targeted therapies. Gene therapy is a potential area of exploration for future treatments.
See Also
==
- Parker, S. (2021). "A New Syndrome: Stratton Parker Syndrome." Journal of Rare Diseases.
- Smith, J. et al. (2022). "Genetic Insights into Stratton Parker Syndrome." Genetics in Medicine.
NIH genetic and rare disease info
Stratton Parker syndrome is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Stratton Parker syndrome
|